MARSHALL WACE ASIA Ltd Purchases New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

MARSHALL WACE ASIA Ltd purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the first quarter, Holdings Channel reports. The fund purchased 6,547 shares of the medical equipment provider’s stock, valued at approximately $3,736,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Bronfman E.L. Rothschild L.P. increased its position in shares of Intuitive Surgical by 1.7% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,239 shares of the medical equipment provider’s stock worth $593,000 after acquiring an additional 21 shares during the period. Destination Wealth Management increased its holdings in Intuitive Surgical by 14.0% in the first quarter. Destination Wealth Management now owns 171 shares of the medical equipment provider’s stock valued at $98,000 after buying an additional 21 shares during the last quarter. Wetherby Asset Management Inc. increased its holdings in Intuitive Surgical by 1.3% in the first quarter. Wetherby Asset Management Inc. now owns 1,684 shares of the medical equipment provider’s stock valued at $961,000 after buying an additional 21 shares during the last quarter. Shine Investment Advisory Services Inc. increased its holdings in Intuitive Surgical by 14.6% in the first quarter. Shine Investment Advisory Services Inc. now owns 180 shares of the medical equipment provider’s stock valued at $103,000 after buying an additional 23 shares during the last quarter. Finally, Cerity Partners LLC increased its holdings in Intuitive Surgical by 3.7% in the fourth quarter. Cerity Partners LLC now owns 673 shares of the medical equipment provider’s stock valued at $322,000 after buying an additional 24 shares during the last quarter. Institutional investors and hedge funds own 85.53% of the company’s stock.

Shares of ISRG traded down $6.19 during mid-day trading on Friday, hitting $499.41. 8,012 shares of the company’s stock were exchanged, compared to its average volume of 744,316. Intuitive Surgical, Inc. has a fifty-two week low of $430.24 and a fifty-two week high of $589.32. The company has a market capitalization of $58.19 billion, a price-to-earnings ratio of 52.52, a price-to-earnings-growth ratio of 4.38 and a beta of 1.06.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.70 by ($0.09). Intuitive Surgical had a return on equity of 17.33% and a net margin of 29.78%. The business had revenue of $974.00 million for the quarter, compared to analyst estimates of $975.27 million. During the same quarter last year, the company posted $2.44 EPS. Intuitive Surgical’s quarterly revenue was up 14.9% on a year-over-year basis. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.4 earnings per share for the current fiscal year.

ISRG has been the subject of several research analyst reports. Canaccord Genuity restated a “buy” rating and issued a $575.00 price objective (down previously from $610.00) on shares of Intuitive Surgical in a research note on Monday, April 22nd. Citigroup decreased their price objective on shares of Intuitive Surgical from $684.00 to $611.00 and set a “buy” rating for the company in a research note on Tuesday, April 23rd. BidaskClub upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday. Piper Jaffray Companies restated an “overweight” rating and issued a $610.00 price objective on shares of Intuitive Surgical in a research note on Thursday, April 18th. Finally, Royal Bank of Canada set a $560.00 price objective on shares of Intuitive Surgical and gave the company a “hold” rating in a research note on Thursday, February 28th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the stock. Intuitive Surgical has a consensus rating of “Buy” and an average target price of $576.82.

In other news, VP Jamie Samath sold 260 shares of the stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $500.00, for a total transaction of $130,000.00. Following the completion of the sale, the vice president now owns 278 shares in the company, valued at $139,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Lonnie M. Smith sold 227 shares of the stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $493.39, for a total transaction of $111,999.53. Following the sale, the director now owns 359,696 shares of the company’s stock, valued at approximately $177,470,409.44. The disclosure for this sale can be found here. Insiders have sold 27,621 shares of company stock valued at $13,828,454 in the last quarter. Insiders own 1.70% of the company’s stock.

WARNING: This news story was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at https://www.themarketsdaily.com/2019/06/14/marshall-wace-asia-ltd-purchases-new-stake-in-intuitive-surgical-inc-nasdaqisrg.html.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: Diversification in Investing

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.